Akros Monthly Payout Etf Current Ratio
| MPAY Etf | USD 0.37 25.77 98.60% |
Akros Monthly Payout fundamentals help investors to digest information that contributes to Akros Monthly's financial success or failures. It also enables traders to predict the movement of Akros Etf. The fundamental analysis module provides a way to measure Akros Monthly's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akros Monthly etf.
Akros |
Akros Monthly Payout ETF Current Ratio Analysis
Akros Monthly's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Akros Monthly Current Ratio | 0.06 X |
Most of Akros Monthly's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akros Monthly Payout is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Akros Monthly Payout has a Current Ratio of 0.06 times. This is much higher than that of the Cabana family and significantly higher than that of the Moderate Allocation category. The current ratio for all United States etfs is notably lower than that of the firm.
Akros Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akros Monthly's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Akros Monthly could also be used in its relative valuation, which is a method of valuing Akros Monthly by comparing valuation metrics of similar companies.Akros Monthly is currently under evaluation in current ratio as compared to similar ETFs.
Fund Asset Allocation for Akros Monthly
The fund invests most of its assets under management in various types of exotic instruments, with the rest of asset invested in stocks.Asset allocation divides Akros Monthly's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Akros Fundamentals
| Return On Equity | -181.7 | |||
| Return On Asset | -285.95 | |||
| Profit Margin | (260.32) % | |||
| Operating Margin | (234.69) % | |||
| Current Valuation | 1.25 M | |||
| Shares Outstanding | 14.29 M | |||
| Shares Owned By Insiders | 38.95 % | |||
| Price To Earning | (0.69) X | |||
| Price To Book | 60.00 X | |||
| Price To Sales | 0.39 X | |||
| Revenue | 407.98 K | |||
| Gross Profit | 438.28 K | |||
| EBITDA | (954.29 K) | |||
| Net Income | (1.06 M) | |||
| Cash And Equivalents | 23.87 K | |||
| Total Debt | 1.11 M | |||
| Debt To Equity | 247.30 % | |||
| Current Ratio | 0.06 X | |||
| Book Value Per Share | (0.10) X | |||
| Cash Flow From Operations | (475.03 K) | |||
| Earnings Per Share | (4.53) X | |||
| Market Capitalization | 158.56 K | |||
| Total Asset | 2.21 M | |||
| Retained Earnings | (6.33 M) | |||
| Working Capital | (222.36 K) | |||
| Current Asset | 318.83 K | |||
| Current Liabilities | 541.18 K | |||
| One Year Return | 26.50 % | |||
| Net Asset | 2.21 M | |||
| Equity Positions Weight | 4.53 % |
About Akros Monthly Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akros Monthly Payout's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akros Monthly using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akros Monthly Payout based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Akros Monthly Payout offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akros Monthly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akros Monthly Payout Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Akros Monthly Payout Etf:Check out Akros Monthly Piotroski F Score and Akros Monthly Altman Z Score analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
The market value of Akros Monthly Payout is measured differently than its book value, which is the value of Akros that is recorded on the company's balance sheet. Investors also form their own opinion of Akros Monthly's value that differs from its market value or its book value, called intrinsic value, which is Akros Monthly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akros Monthly's market value can be influenced by many factors that don't directly affect Akros Monthly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akros Monthly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akros Monthly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akros Monthly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.